Fate Therapeutics Inc

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+398K	50.8%	$1.68	+$669K
Sells	4	-385K	49.2%	$1.64	-$630K
Net	-3	+12.5K	1.6%		+$38.2K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Redmile Group, LLC	Director, 10%+ Owner	$45.7M	+$94.6K	+0.21%	May 29, 2025
RedCo II Master Fund, L.P.	Director, 10%+ Owner	$9.34M			Jul 2, 2025
Bahram Valamehr	President and CEO, Director	$3.91M	-$28.8K	-0.73%	Aug 4, 2025
J. Scott Wolchko	President and CEO, Director	$2.99M			Feb 1, 2024
Edward J. Dulac III	Chief Financial Officer	$1.95M			Mar 4, 2024
Yu-Waye Chu	Chief Medical Officer	$1.78M			Apr 18, 2023
Brian Powl	Chief Commercial Officer	$1.34M			Jul 5, 2023
Jerome Charles Bressi	Chief Regulatory and Quality Officer	$1.2M	-$9.27K	-0.77%	Jan 15, 2025
Cindy Tahl	Chief Legal and Compliance Officer	$1.17M	-$18.3K	-1.54%	Aug 4, 2025
Mark Plavsic	Chief Technical Officer	$685K			Jan 10, 2023
Neelufar Mozaffarian	Director	$218K			May 29, 2025
Robert Hershberg	Director	$156K			Jun 6, 2023
Yuan Xu	Director	$146K			May 29, 2025
Karin Jooss	Director	$109K			May 29, 2025
Shefali Agarwal	Director	$109K			May 29, 2025
William H. Rastetter	Director	$109K			May 29, 2025
John Mendlein	Director	$109K			May 29, 2025
Timothy Coughlin	Director	$109K			Jun 7, 2024
Robert S. Epstein	Director	$109K			May 29, 2025
Michael Lee	Director	$109K			May 29, 2025
Kamal Adawi	Chief Financial Officer	$94.5K			Oct 20, 2025
Matt Abernethy	Director				May 29, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.